Literature DB >> 12351514

Tenascin-C levels in the vitreous of patients with proliferative diabetic retinopathy.

Yoshinori Mitamura, Shinobu Takeuchi, Kenji Ohtsuka, Akira Matsuda, Noriko Hiraiwa, Moriaki Kusakabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12351514     DOI： 10.2337/diacare.25.10.1899

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Authors:  Tammy L Palenski; Christine M Sorenson; Nader Sheibani
Journal:  Microvasc Res       Date:  2013-06-24       Impact factor: 3.514

Review 2.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

Review 3.  Diabetic Retinopathy: Vascular and Inflammatory Disease.

Authors:  F Semeraro; A Cancarini; R dell'Omo; S Rezzola; M R Romano; C Costagliola
Journal:  J Diabetes Res       Date:  2015-06-07       Impact factor: 4.011

Review 4.  Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.

Authors:  Binapani Mahaling; Shermaine W Y Low; Molly Beck; Devesh Kumar; Simrah Ahmed; Thomas B Connor; Baseer Ahmad; Shyam S Chaurasia
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

5.  Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.

Authors:  Yoshiyuki Kobayashi; Shigeo Yoshida; Yedi Zhou; Takahito Nakama; Keijiro Ishikawa; Mitsuru Arima; Shintaro Nakao; Yukio Sassa; Atsunobu Takeda; Toshio Hisatomi; Yasuhiro Ikeda; Akira Matsuda; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.